These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8198934)

  • 21. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV; Howes J; Sharma V; Kadziola Z
    Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment.
    Dorr LD; Gendelman V; Maheshwari AV; Boutary M; Wan Z; Long WT
    J Bone Joint Surg Am; 2007 Dec; 89(12):2648-57. PubMed ID: 18056497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prevention of venous thrombosis: role of heparins].
    Wahl D; Lepaux DJ; Piquemal R; Frédéric M; Cayrol C; Lecompte T; Thibaut G
    Therapie; 1998; 53(6):575-8. PubMed ID: 10070236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Venous thromboembolism prophylaxis in the critically ill: a point prevalence survey of current practice in Australian and New Zealand intensive care units.
    Robertson MS; Nichol AD; Higgins AM; Bailey MJ; Presneill JJ; Cooper DJ; Webb SA; McArthur C; MacIsaac CM; ;
    Crit Care Resusc; 2010 Mar; 12(1):9-15. PubMed ID: 20196708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction of venous thromboembolism following prolonged prophylaxis with the low molecular weight heparin Certoparin after endoprothetic joint replacement or osteosynthesis of the lower limb in elderly patients.
    Kolb G; Bodamer I; Galster H; Seidlmayer C; Grambach K; Koudela K; Eisele RR; Becker C; Paal V; Spannagel U; Brom J; Weidinger G;
    Thromb Haemost; 2003 Dec; 90(6):1100-5. PubMed ID: 14652643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Results of ENDORSE-2-HUNGARIA study. Repeated assessment of the prevalence of venous thromboembolism risk and prophylaxis in acute hospital care setting].
    Losonczy H; Tar A
    Orv Hetil; 2010 May; 151(21):843-52. PubMed ID: 20462844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada.
    Kahn SR; Panju A; Geerts W; Pineo GF; Desjardins L; Turpie AG; Glezer S; Thabane L; Sebaldt RJ;
    Thromb Res; 2007; 119(2):145-55. PubMed ID: 16516275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Venous thromboembolism prophylaxis in emergency department admissions.
    Levine RL; Hergenroeder GW; Miller CC; Davies A
    J Hosp Med; 2007 Mar; 2(2):79-85. PubMed ID: 17427248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Duplex screening as a method of quality assurance of perioperative thromboembolism prophylaxis.
    Van Den Berg E; Bathgate B; Panagakos E; Lambrechts R; Hani M; Meissner A; Schröder M
    Int Angiol; 1999 Sep; 18(3):210-9. PubMed ID: 10688420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of once-daily dose of low-molecular-weight heparin to prevent venous thromboembolism in multisystem trauma patients.
    Cothren CC; Smith WR; Moore EE; Morgan SJ
    World J Surg; 2007 Jan; 31(1):98-104. PubMed ID: 17180563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Thromboembolic risk and prophylaxis in hospitalized surgical and internal medicine patients. German results of the international ENDORSE study].
    Zotz RB; Kauschat-Brüning D; Bramlage P;
    Dtsch Med Wochenschr; 2009 Oct; 134(43):2163-9. PubMed ID: 19826978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physicians' practice for prevention of venous thromboembolism in medical patients.
    Abba AA; Al Ghonaim MA; Rufai AM
    J Coll Physicians Surg Pak; 2004 Apr; 14(4):211-4. PubMed ID: 15228823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Assessing the use of low-molecular-weight heparins fo venous thromboembolism prophylaxis in internal medicine patients].
    Villar Fernández I; Urbieta Sanz E; Arenere Mendoza M; López Larramona G; Marcilla Córdoba F; Rabanaque Hernández MJ
    Farm Hosp; 2004; 28(6):402-9. PubMed ID: 15628942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thromboembolism complicating surgery for cervical and uterine malignancy: incidence, risk factors, and prophylaxis.
    Clarke-Pearson DL; Jelovsek FR; Creasman WT
    Obstet Gynecol; 1983 Jan; 61(1):87-94. PubMed ID: 6823353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-molecular-weight heparins for the prevention of recurrent venous thromboembolism in patients with cancer: A systematic literature review of efficacy and cost-effectiveness.
    Dranitsaris G; Shane LG; Woodruff S
    J Oncol Pharm Pract; 2019 Jan; 25(1):68-75. PubMed ID: 28857713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of venous thromboembolism in Wales: results of a survey among general surgeons.
    Williams EV; Williams RS; Hughes JL; Williams KL; Foster ME; Lewis MH
    Postgrad Med J; 2002 Feb; 78(916):88-91. PubMed ID: 11807190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacoeconomic analysis of bemiparin and enoxaparin as prophylaxis for venous thromboembolism in total knee replacement surgery.
    Honorato J; Gómez-Outes A; Navarro-Quilis A; Martínez-González J; Rocha E; Planès A
    Pharmacoeconomics; 2004; 22(13):885-94. PubMed ID: 15329033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prophylaxis of venous thromboembolism using two different doses of low-molecular-weight heparin (nadroparin) in bariatric surgery: a prospective randomized trial.
    Kalfarentzos F; Stavropoulou F; Yarmenitis S; Kehagias I; Karamesini M; Dimitrakopoulos A; Maniati A
    Obes Surg; 2001 Dec; 11(6):670-6. PubMed ID: 11775562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prevention of thromboembolism with low-molecular-weight heparin in ambulatory surgery and unoperated surgical and orthopedic patients].
    Harenberg J; Piazolo L; Misselwitz F
    Zentralbl Chir; 1998; 123(11):1284-7. PubMed ID: 9880848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prophylaxis of venous thrombosis, yes but...].
    Korin JD; Sánchez Avalos JC
    Medicina (B Aires); 1996; 56(3):299-307. PubMed ID: 9035489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.